Literature DB >> 4299942

Demonstration of cell-bound and humoral immunity against neuroblastoma cells.

I E Hellström, K E Hellström, G E Pierce, A H Bill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4299942      PMCID： PMC224908          DOI： 10.1073/pnas.60.4.1231

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  12 in total

1.  IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS.

Authors:  J B BECKWITH; E V PERRIN
Journal:  Am J Pathol       Date:  1963-12       Impact factor: 4.307

2.  Immunity to methylcholanthrene-induced sarcomas.

Authors:  R T PREHN; J M MAIN
Journal:  J Natl Cancer Inst       Date:  1957-06       Impact factor: 13.506

Review 3.  Antigenic structure of chemically-induced hepatomas.

Authors:  G I Abelev
Journal:  Prog Exp Tumor Res       Date:  1965

4.  Demonstration of H-2 isoantigens and polyoma specific tumor antigens by measuring colony formation in vitro.

Authors:  I Hellström; H O Sjögren
Journal:  Exp Cell Res       Date:  1965-10       Impact factor: 3.905

5.  In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs.

Authors:  I Hellström; K E Hellström; G E Pierce
Journal:  Int J Cancer       Date:  1968-07-15       Impact factor: 7.396

Review 6.  Tumor antigens.

Authors:  G Klein
Journal:  Annu Rev Microbiol       Date:  1966       Impact factor: 15.500

7.  Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction.

Authors:  G Klein; P Clifford; E Klein; J Stjernswärd
Journal:  Proc Natl Acad Sci U S A       Date:  1966-06       Impact factor: 11.205

8.  Cell-bound immunity to autologous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs.

Authors:  I Hellström; K E Hellström
Journal:  Science       Date:  1967-05-19       Impact factor: 47.728

9.  Specific carcinoembryonic antigens of the human digestive system.

Authors:  P Gold; S O Freedman
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

10.  In vitro demonstration of humoral and cell-bound immunity against common specific transplantation atigen(s) of adenovirus 12-induced mouse and hamster tumors.

Authors:  I Hellström; H O Sjögren
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307
View more
  46 in total

1.  Lymphocyte responsiveness to phytohemagglutinin (PHA) and serum inhibitory effect in patients with gastric cancer.

Authors:  T Toge; H Ikeda; N Senoo; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1976-12

2.  The role of circulating antibody in the control of metastases.

Authors:  M G Lewis
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

3.  The influence of cyclophosphamide on the rejection of allogenic rat kidney transplants. An in vitro study of cell-bound and antibody-mediated immunity.

Authors:  B S Husberg
Journal:  Clin Exp Immunol       Date:  1972-04       Impact factor: 4.330

Review 4.  Recurrent and metastatic malignant disease: immunological considerations.

Authors:  R L Carter
Journal:  Proc R Soc Med       Date:  1974-09

5.  In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.

Authors:  S M Jagarlamoody; J C Aust; R H Tew; C F McKhann
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

6.  Antigens of nasopharyngeal carcinoma.

Authors:  D S Nelson
Journal:  Clin Exp Immunol       Date:  1971-06       Impact factor: 4.330

7.  Heterologous antibodies in human and rat's glioblastoma.

Authors:  J E Roda; F Villarejo; J Heredero; S Obrador
Journal:  Acta Neurochir (Wien)       Date:  1976       Impact factor: 2.216

8.  Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease.

Authors:  W E Brandeis; L Helson; Y Wang; R A Good; N K Day
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

9.  KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

Authors:  Jeffrey M Venstrom; Junting Zheng; Nabila Noor; Karen E Danis; Alice W Yeh; Irene Y Cheung; Bo Dupont; Richard J O'Reilly; Nai-Kong V Cheung; Katharine C Hsu
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

10.  Antibody-dependent cellular cytotoxicity-mediated serotherapy against murine neuroblastoma. II. In vitro and in vivo treatment using effector cells from normal and X-irradiated humans.

Authors:  J E Byfield; R Zerubavel; E W Fonkalsrud
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.